Page results
-
Patient information which describes what miscarriages are, and why they occur, explains what treatment options are available, describes expectant management in detail, explains what can be expected during your recovery from a miscarriage and discusses future pregnancies.
-
This information is for patients who are having radiotherapy to the pelvis.
-
At UCLH we use many different drugs to treat patients with cancer. Chemotherapy is the treatment of cancer with drugs designed to control or destroy the growth of the tumour.
-
The Central Venous Access Device team provides a nurse-led service to teenagers and adults who have been referred to UCLH for cancer treatment.
-
Dr Swayne is a consultant neurologist with a special interest in neurorehabilitation and stroke.
-
UCLH is the only Supra-Centre in England to deliver Intracranial Stereotactic Radiosurgery and Stereotactic Radiotherapy Services (SRS/SRT) as part of an integrated neurosurgical and neuro-oncology service to patients.
-
The lymphoedema service at UCLH provides assessment, diagnosis, treatment and management of cancer-related lymphoedema.
-
Patient information for patients who are having a bone marrow biopsy.
-
The Headache and Facial Pain Group is internationally recognised as a centre of clinical and academic excellence in the management of complex head and facial pain disorders.
-
UCLH provides a comprehensive service to diagnose, treat and support people with cancer. We are a specialist centre for many types of cancer and treat patients from both our local area and across the country.
File results
-
FOI/2022/0531 - Operating theatres in Trust
-
FOI/2022/0533 - Pathology service carrying out PCR testing for SARS-CoV2
-
FOI/2022/0539 - Pharmacological choices made for patients undergoing joint replacement surgery
-
FOI/2022/0557 - Patients treated with Visudyne (verteporfin)
-
FOI/2022/0563 - Ambulatory cardiac monitoring
-
FOI/2022/0544 - Wards/ departments that provide services to 0-17 year-olds
-
FOI/2022/0545 - Criteria used in determining acceptance of GP referrals for osteoporosis treatment, and for priorisation of osteoporosis appointments
-
FOI/2022/0546 - Metastatic Cholangiocarcinoma (CCA) or Acute myeloid leukaemia
-
FOI/2022/0548 - Biologic and biosimilar products within Rheumatology
-
FOI/2022/0549 - SACT (systemic anti-cancer therapy) /cervical cancer treatments